Liangliang Wu

Beijing Institute of Aeronautical Materials — China

Medicine · Health Sciences

23h-index1.4kcitations105works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(24), Cancer Immunotherapy and Biomarkers(23), Metastasis and carcinoma case studies(18), Pancreatic and Hepatic Oncology Research(17), Drug Transport and Resistance Mechanisms(13)

Publications105 total

Time lapse X-ray imaging reveals dual-role significance of hot cracks in high-temperature fatigued L-PBF Hastelloy X
International Journal of Fatigue·2026
Symmetric Orchestration Under Service Mesh Paradigm: Empowering Massive Online Applications in Edge Clouds
IEEE Transactions on Mobile Computing·2025
Effects of Secondary Orientation and Recrystallization Grains on the Low‐Cycle Fatigue Behavior of DD6 Single Crystal Superalloy
Fatigue & Fracture of Engineering Materials & Structures·2025Open Access
Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer
BMC Cancer·2025Open Access
WITHDRAWN: 1865P Association between immune-related adverse events and clinical outcomes in non-small cell lung cancer patients treated with chemo-immunotherapy: A post hoc analysis of the phase III choice-01 trial
Annals of Oncology·2025
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage <scp>IV</scp> gastric cancer
International Journal of Cancer·2025· 2 citedOpen Access
Effects of secondary orientation and recrystallization grains on the low-cycle fatigue behavior of DD6 single crystal superalloy
2025
Adipocyte ZAG improves obesity-triggered insulin resistance by reshaping macrophages populations in adipose tissue
International Immunopharmacology·2025· 2 cited
Identification of the entosis-related prognostic signature and tumour microenvironment in hepatocellular carcinoma on the basis of bioinformatics analysis and experimental validation
Clinical and Experimental Medicine·2025Open Access
Prediction of Hepatocellular Carcinoma Prognosis and Immunotherapy Response Using Mitochondrial Dysregulation Features
Journal of Cellular and Molecular Medicine·2025· 1 citedOpen Access
Immunological characteristics of peripheral T cells as prognostic markers for Camrelizumab and Apatinib combination therapy in advanced squamous non-small-cell lung cancer
Molecular Immunology·2025Open Access
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment
Annals of Hematology·2025Open Access
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Clinical & Translational Oncology·2024· 7 cited
Long-term adoptive immunotherapy achieves complete response and bone lesion repair in an elderly patient with macrofocal multiple myeloma
Cancer Pathogenesis and Therapy·2024· 1 citedOpen Access
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
Journal of Cancer Research and Clinical Oncology·2024· 4 citedOpen Access
Comparison of 3 diagnostic methods for pulmonary tuberculosis in suspected patients with negative sputum smear or no sputum
Medicine·2024· 2 citedOpen Access
Revealing splenectomy-driven microRNA hsa-7b-5p’s role in pancreatic cancer progression
iScience·2024· 1 citedOpen Access
Neoadjuvant nivolumab plus chemotherapy versus chemotherapy for resectable NSCLC: subpopulation analysis of Chinese patients in CheckMate 816
ESMO Open·2023· 12 citedOpen Access
656MO The HER2-targeting ADC SHR-A1811 in HER2-expressing/mutated advanced non-breast solid tumors (STs): Results from the global phase I study
Annals of Oncology·2023· 6 citedOpen Access
The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma
Translational Oncology·2023· 9 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Han Liang(11), Xuewei Ding(10), Weiwei Tang(8), Baogui Wang(8), Ye Cheng(7), Rupeng Zhang(7), Lingxiong Wang(6), Yuexiang Liang(6), Qiyan Wu(6), Jingyu Deng(6), Guoqiang Sun(6), Xiaona Wang(6), Shunchang Jiao(5), Yi Hu(4), Zhouxiao Li(4), Fan Wu(4), Hongyong Cao(4), Shunchang Jiao(4), Yuan Pan(4), Xishan Hao(4)